Table 2.
No. of cases |
Diameter of metastases (mm3) |
Evaluation of response (according to RECIST) | Adverse events grade | |
Pre-chem | Post-chem | |||
1 | 128 | 0-10 | CR | 2 |
2 | 135 | 56 | PR | 3 |
3 | 188 | 65 | PR | 1 |
4 | 64 | 22 | PR | 2 |
5 | 48 | 24 | PR | 2 |
6 | 148 | 38 | PR | 1 |
7 | 205 | 83 | PR | 1 |
8 | 162 | 65 | PR | 2 |
9 | 78 | 30 | PR | 2 |
10 | 228 | 94 | PR | 3 |
11 | 206 | 108 | PR | 2 |
12 | 144 | 56 | PR | 1 |
13 | 67 | 41 | PR | 1 |
14 | 104 | 67 | PR | 3 |
15 | 163 | 103 | PR | 2 |
16 | 134 | 92 | PR | 3 |
17 | 88 | 61 | PR | 3 |
18 | 225 | 134 | PR | 2 |
19 | 143 | 96 | PR | 2 |
20 | 78 | 43 | PR | 3 |
When the number of liver lesions was > 5, the diameters of the five largest lesions were summed. RECIST: Response evaluation criteria in solid tumors; CR: Complete response; PR: Partial response; Pre-chem: Pre-chemotherapy; Post-chem: Post-chemotherapy.